IAG to Attend Biotech Week of Meetings in San Francisco, USA, 12-15 January 2020
IAGs’ bio-partnering and management team will be attending biotech week in San Francisco. IAG’s CEO, Dr. Olga Kubassova will attend JP Morgan meeting and Bio-Partnering Director and Head of Therapeutic Innovation, Dr. Diana Roettger will be attending Biotech Showcase and satellite events in San Francisco, USA, from January 12-15, 2020.
‘We see an increasing demand for an expert driven targeted development strategy, that often brings together smart use of technology, advanced imaging and AI. This de-risks biotech investors risks and increases changes of success, especially in early efficacy studies,’ said Dr. Diana Roettger of IAG.
‘Our Bio-Partnering team has signed 6 successful partnerships with blue-chip pharma companies, public and private biotechnology players in 2019. We are excited to start 2020 and look forward to attending biotech week in San Francisco’, added Dr. Olga Kubassova, CEO of IAG.
About Image Analysis Group (IAG)
IAG, Image Analysis Group is a unique partner to life sciences companies. IAG leverages expertise in medical imaging and the power of Dynamika™ – our proprietary cloud-based platform, to de-risk clinical development and deliver lifesaving therapies into the hands of patients much sooner. IAG provides early drug efficacy assessments, smart patient recruitment and predictive analysis of advanced treatment manifestations, thus lowering investment risk and accelerating study outcomes. IAG bio-partnering takes a broader view on asset development bringing R&D solutions, operational breadth, radiological expertise via risk-sharing financing and partnering models.
Learn more: www.ia-grp.com
Reach out: firstname.lastname@example.org
Follow the Company: Linkedin